Search research articles
Contact Us
Filters
Showing results (1221-1230 of 1,289) with videos related to
Page
of 129
Sort By:
Journal of the National Cancer Institute. Monographs
|
May 16, 2020
An Evaluation of the Utility of Big Data to Supplement Cancer Treatment Information: Linkage Between IQVIA Pharmacy Database and the Surveillance, Epidemiology, and End Results Program
Quyen Tran, Joan L Warren, Michael J Barrett, et al.
Neurology
|
August 8, 2008
PINK1 mutations and parkinsonism
L Ishihara-Paul, M M Hulihan, J Kachergus, et al.
The Lancet. Microbe
|
July 2, 2026
Lineage-specific transmission and spatial clustering of Mycobacterium tuberculosis in Kaohsiung, Taiwan, in 2019-23: a population-based genomic study
Chieh-Yin Wu, Ying-An Chen, Thomas R Ioerger, et al.
Plos Medicine
|
February 22, 2022
Phylogeography and transmission of M. tuberculosis in Moldova: A prospective genomic analysis
Chongguang Yang, Benjamin Sobkowiak, Vijay Naidu, et al.
Lancet (London, England)
|
May 25, 2005
Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS)
M O Leach, C R M Boggis, A K Dixon, et al.
Targeted Oncology
|
October 22, 2020
Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Julie G Fisher, David Tait, Elizabeth Garrett-Mayer, et al.
PLOS Global Public Health
|
September 27, 2023
Persuasive COVID-19 vaccination campaigns on Facebook and nationwide vaccination coverage in Ukraine, India, and Pakistan
Maike Winters, Sarah Christie, Chelsey Lepage, et al.
The Pharmacogenomics Journal
|
August 9, 2017
Characterisation of the HLA-DRB1*07:01 biomarker for lapatinib-induced liver toxicity during treatment of early-stage breast cancer patients with lapatinib in combination with trastuzumab and/or taxanes
C F Spraggs, L R Parham, L P Briley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2009
Multicenter, phase I, dose-escalation trial of lenalidomide plus bortezomib for relapsed and relapsed/refractory multiple myeloma
Paul G Richardson, Edie Weller, Sundar Jagannath, et al.
Elife
|
October 4, 2021
Parallel functional testing identifies enhancers active in early postnatal mouse brain
Jason T Lambert, Linda Su-Feher, Karol Cichewicz, et al.
Page
of 129
Search research articles
Search
Showing results (1221-1230 of 1,289) with videos related to
Sort By:
Page
of 129
Journal of the National Cancer Institute. Monographs
|
May 16, 2020
An Evaluation of the Utility of Big Data to Supplement Cancer Treatment Information: Linkage Between IQVIA Pharmacy Database and the Surveillance, Epidemiology, and End Results Program
Quyen Tran, Joan L Warren, Michael J Barrett, et al.
Neurology
|
August 8, 2008
PINK1 mutations and parkinsonism
L Ishihara-Paul, M M Hulihan, J Kachergus, et al.
The Lancet. Microbe
|
July 2, 2026
Lineage-specific transmission and spatial clustering of Mycobacterium tuberculosis in Kaohsiung, Taiwan, in 2019-23: a population-based genomic study
Chieh-Yin Wu, Ying-An Chen, Thomas R Ioerger, et al.
Plos Medicine
|
February 22, 2022
Phylogeography and transmission of M. tuberculosis in Moldova: A prospective genomic analysis
Chongguang Yang, Benjamin Sobkowiak, Vijay Naidu, et al.
Lancet (London, England)
|
May 25, 2005
Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS)
M O Leach, C R M Boggis, A K Dixon, et al.
Targeted Oncology
|
October 22, 2020
Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Julie G Fisher, David Tait, Elizabeth Garrett-Mayer, et al.
PLOS Global Public Health
|
September 27, 2023
Persuasive COVID-19 vaccination campaigns on Facebook and nationwide vaccination coverage in Ukraine, India, and Pakistan
Maike Winters, Sarah Christie, Chelsey Lepage, et al.
The Pharmacogenomics Journal
|
August 9, 2017
Characterisation of the HLA-DRB1*07:01 biomarker for lapatinib-induced liver toxicity during treatment of early-stage breast cancer patients with lapatinib in combination with trastuzumab and/or taxanes
C F Spraggs, L R Parham, L P Briley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2009
Multicenter, phase I, dose-escalation trial of lenalidomide plus bortezomib for relapsed and relapsed/refractory multiple myeloma
Paul G Richardson, Edie Weller, Sundar Jagannath, et al.
Elife
|
October 4, 2021
Parallel functional testing identifies enhancers active in early postnatal mouse brain
Jason T Lambert, Linda Su-Feher, Karol Cichewicz, et al.
Page
of 129